[Nicotinic acid in the treatment of chronic circulatory failure in patients with ischemic heart disease].
Examined were 98 patients with chronic forms of ischemic heart disease, mainly atherosclerotic cardiosclerosis with different degrees of cardiac insufficiency. Two groups were distinguished. Patients of the first group received traditional treatment while patients of the second group received also nicotinic acid agents. It was found that inclusion of nicotinic acid in the complex treatment of patients with ischemic heart disease increased the therapeutic efficacy.
Kats
G L
GL
Zhivotovskaia
I A
IA
Gnilitskaia
V B
VB
Alifanova
R E
RE
Mal'tseva
N V
NV
D000368:Aged; D000369:Aged, 80 and over; D003327:Coronary Disease / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D004341:Drug Evaluation; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009525:Niacin / Q000627:therapeutic use*
D009525:Niacin
Nikotinovaia kislota v lechenii khronicheskoĭ nedostatochnosti krovoobrashcheniia u bol'nykh ishemicheskoĭ bolezn'iu serdtsa.